Inflammation

, Volume 34, Issue 4, pp 231–237

Nicotine Exerts an Anti-inflammatory Effect in a Murine Model of Acute Lung Injury

Article

DOI: 10.1007/s10753-010-9228-x

Cite this article as:
Mabley, J., Gordon, S. & Pacher, P. Inflammation (2011) 34: 231. doi:10.1007/s10753-010-9228-x

Abstract

Activation of the cholinergic anti-inflammatory pathway through direct activation of nicotinic acetylcholine receptors on immune cells can inhibit pro-inflammatory chemokine and cytokine release and thereby protect in a variety of inflammatory diseases. The aim of this study was to investigate whether nicotine treatment protected against acute lung inflammation. Mice challenged with intratracheal lipopolysaccharide (LPS, 50 μg) were treated with nicotine (0.2 or 0.4 mg/kg, sc). After 24 h, bronchoalveolar lavage fluid (BALF) was obtained to measure leukocyte infiltration, lung edema, and pro-inflammatory chemokine (MIP-1α, MIP-2, and eotaxin) and cytokine (IL-1, IL-6, and TNF-α) levels. Nicotine treatment reduced the LPS-mediated infiltration of leukocytes and edema as evidenced by decreased BALF inflammatory cells, myeloperoxidase, and protein. Nicotine also downregulated lung production of pro-inflammatory chemokines and cytokines. These data support the proposal that activation of the cholinergic anti-inflammatory pathway may represent a useful addition to the therapy of acute respiratory distress syndrome.

KEY WORDS

inflammation nicotine acetylcholine lung chemokine 

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.School of Pharmacy & Biomolecular SciencesUniversity of BrightonBrightonUK
  2. 2.Section on Oxidative Stress Tissue injury, Laboratory of Physiological StudiesNational Institutes of Health/NIAAABethesdaUSA

Personalised recommendations